Boehringer Ingelheim and Lilly initiate MARLINA™ clinical trial to evaluate use of Trajenta® (linagliptin) in patients with type 2 diabetes and albuminuria
For Non-U.S. and Non-U.K. Media
Boehringer Ingelheim Animal Health sponsors PCV2 research projects with more than 400,000 euro
American College of Cardiology and Boehringer Ingelheim collaborate to advance physician education with focus on China in 2013
For Non-US, Non-UK & Non-Canadian Media Only
Pharmaco-invasive strategy including Metalyse® delivers comparable clinical outcomes to primary PCI for STEMI patients who could not undergo primary PCI within one hour from first medical contact
For NON-U.S. Media Only
Boehringer Ingelheim announces interim results from a Phase III trial in HIV patients co-infected with chronic hepatitis C
For media outside of the U.S.A., UK and Canada only
